Details

Structure visualisation

Display styles :





Display color :





Entry information

Complex
AACDB_ID: 3288
PDBID: 6YZ7
Chains: D_A
Organism: Severe acute respiratory syndrome coronavirus 2, Homo sapiens, Lama glama
Method: XRD
Resolution (Å): 3.30
Reference: Not available or To be published
Antibody
Antibody: 6YZ7 Nanobody
Antibody mutation: No
INN (Clinical Trial):
Antigen
Antigen: SARS-CoV-2 Spike glycoprotein RBD
Antigen mutation: No
Durg Target: P0DTC2; P0DTC2;

Sequence information

Antibody

Chain: D
Mutation: NULL

>6YZ7_D|Chain D[auth DDD], F[auth FFF]|Nanobody|Lama glama (9844)
QVQLVESGGGLMQAGGSLRLSCAVSGRTFSTAAMGWFRQAPGKEREFVAAIRWSGGSAYYADSVKGRFTISRDKAKNTVYLQMNSLKYEDTAVYYCARTENVRSLLSDYATWPYDYWGQGTQVTVSSKHHHHHH

Antigen

Chain: A
Mutation: NULL

>6YZ7_A|Chain A[auth AAA], E[auth EEE]|Spike glycoprotein|Severe acute respiratory syndrome coronavirus 2 (2697049)
PNITNLCPFGEVFNATRFASVYAWNRKRISNCVADYSVLYNSASFSTFKCYGVSPTKLNDLCFTNVYADSFVIRGDEVRQIAPGQTGKIADYNYKLPDDFTGCVIAWNSNNLDSKVGGNYNYLYRLFRKSNLKPFERDISTEIYQAGSTPCNGVEGFNCYFPLQSYGFQPTNGVGYQPYRVVVLSFELLHAPATVCGPKKSTNKHHHHHH

Interaction

1、Solvent accessible surface areas (SASA) were calculated (Naccess V2.1.1) for each residue in antibody and antigen, respectively. The residues with SASA loss in binding of more than 1Å2 were classified as interacting residues.

Interacting residues (ΔSASA based)

D: PHE29 SER30 ARG52 SER54 GLY55 SER57 ALA58 THR99 GLU100 ASN101 VAL102 ARG103 SER104 LEU105 LEU106 TRP112 PRO113 ASP115

A: ARG17 LYS115 GLY117 TYR120 ASN121 LEU123 LEU126 PHE127 THR141 ILE143 GLY153 VAL154 GLU155 GLY156 TYR160 PHE161 LEU163 GLN164 SER165

2、We defined interacting paratope-epitope residues by a distance cutoff of < 5Å . Two amino acids are considered as interacting residues if they have at least one atom within a distance of 5 Å from any atom.

Interacting residues (Atom distance based)

Download

Download sequences
Download structure
Download interacting residues (ΔSASA based)
Download interacting residues (Distance based)